Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Lurasidone and risk for metabolic syndrome: results from short- and long-term clinical studies in patients with schizophrenia

CNS Spectrums(2020)10.1017/s1092852920001698Source: DataRank Database

Lurasidone and risk for metabolic syndrome: results from short- and long-term clinical studies in patients with schizophrenia is a research paper published in CNS Spectrums (2020). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 0.99)OA: hybridTopics (21)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

John W. Newcomer ORCID,Yongcai Mao,Andrei Pikalov,Antony Loebel ORCID,Michael Tocco ORCID

Live enrichment

PubMed:32921337 OpenAlex:https://openalex.org/W3086858479

FWCI

0.99

Citation Percentile

0.7%

Citation Trend

2021

2022

2023

2024

2026

hybridLicense: cc-by

journalhttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/3AC0E59AF40259C1DC5C4192042CD3F0/S1092852920001698a.pdf/div-class-title-lurasidone-and-risk-for-metabolic-syndrome-results-from-short-and-long-term-clinical-studies-in-patients-with-schizophrenia-div.pdf

publisherhttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/3AC0E59AF40259C1DC5C4192042CD3F0/S1092852920001698a.pdf/div-class-title-lurasidone-and-risk-for-metabolic-syndrome-results-from-short-and-long-term-clinical-studies-in-patients-with-schizophrenia-div.pdf

publisherhttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/S1092852920001698

journalhttps://doi.org/10.1017/s1092852920001698

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32921337

Fields of Study

Schizophrenia research and treatmentAdrenal Hormones and DisordersStress Responses and Cortisol

Keywords

LurasidoneQuetiapineOlanzapineRisperidoneMedicineOdds ratioMetabolic syndromeInternal medicinePlaceboSchizophrenia (object-oriented programming)Atypical antipsychoticAntipsychoticGastroenterologyPsychiatryObesitySchizophreniaAtypicalAntipsychotics